Search research articles
Contact Us
Filters
Showing results (21-30 of 51) with videos related to
Page
of 6
Sort By:
Advances in Laboratory Medicine
|
December 11, 2023
Liver FoxO1 overexpression is positively associated with the degree of liver injury in cirrhotic patients
Esther Fernández-Galán, Silvia Sandalinas, Laura Macias-Muñoz, et al.
Cancers
|
February 7, 2020
Regorafenib Alteration of the BCL-xL/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma Models
Blanca Cucarull, Anna Tutusaus, Miguel Subías, et al.
Frontiers in Immunology
|
May 31, 2024
Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH
Sturla Magnus Grøndal, Anna Tutusaus, Loreto Boix, et al.
Virus Research
|
July 29, 2017
Permissiveness of human hepatocellular carcinoma cell lines for hepatitis C virus entry and replication
Mairene Coto-Llerena, George Koutsoudakis, Loreto Boix, et al.
Oncotarget
|
April 24, 2018
Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma
Anna Tutusaus, Milica Stefanovic, Loreto Boix, et al.
International Journal of Molecular Sciences
|
April 13, 2024
Identification of Dhx15 as a Major Regulator of Liver Development, Regeneration, and Tumor Growth in Zebrafish and Mice
Irene Portolés, Jordi Ribera, Esther Fernandez-Galán, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
September 26, 2025
Polymeric nanoparticles for liver-targeted pituitary tumor-transforming gene 1 silencing in rats with chronic liver disease
Meritxell Perramón, María Navalón-López, Guillermo Fernández-Varo, et al.
Plos One
|
June 1, 2011
Real-time PCR improves Helicobacter pylori detection in patients with peptic ulcer bleeding
María José Ramírez-Lázaro, Sergio Lario, Alex Casalots, et al.
Cancers
|
January 27, 2021
Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma
Josep Corominas, Victor Sapena, Marco Sanduzzi-Zamparelli, et al.
Oncotarget
|
March 22, 2021
Mutational profile of skin lesions in hepatocellular carcinoma patients under tyrosine kinase inhibition: a repercussion of a wide-spectrum activity
Leonardo G da Fonseca, Carla Fuster-Anglada, Cristina Carrera, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 51) with videos related to
Sort By:
Page
of 6
Advances in Laboratory Medicine
|
December 11, 2023
Liver FoxO1 overexpression is positively associated with the degree of liver injury in cirrhotic patients
Esther Fernández-Galán, Silvia Sandalinas, Laura Macias-Muñoz, et al.
Cancers
|
February 7, 2020
Regorafenib Alteration of the BCL-xL/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma Models
Blanca Cucarull, Anna Tutusaus, Miguel Subías, et al.
Frontiers in Immunology
|
May 31, 2024
Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH
Sturla Magnus Grøndal, Anna Tutusaus, Loreto Boix, et al.
Virus Research
|
July 29, 2017
Permissiveness of human hepatocellular carcinoma cell lines for hepatitis C virus entry and replication
Mairene Coto-Llerena, George Koutsoudakis, Loreto Boix, et al.
Oncotarget
|
April 24, 2018
Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma
Anna Tutusaus, Milica Stefanovic, Loreto Boix, et al.
International Journal of Molecular Sciences
|
April 13, 2024
Identification of Dhx15 as a Major Regulator of Liver Development, Regeneration, and Tumor Growth in Zebrafish and Mice
Irene Portolés, Jordi Ribera, Esther Fernandez-Galán, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
September 26, 2025
Polymeric nanoparticles for liver-targeted pituitary tumor-transforming gene 1 silencing in rats with chronic liver disease
Meritxell Perramón, María Navalón-López, Guillermo Fernández-Varo, et al.
Plos One
|
June 1, 2011
Real-time PCR improves Helicobacter pylori detection in patients with peptic ulcer bleeding
María José Ramírez-Lázaro, Sergio Lario, Alex Casalots, et al.
Cancers
|
January 27, 2021
Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma
Josep Corominas, Victor Sapena, Marco Sanduzzi-Zamparelli, et al.
Oncotarget
|
March 22, 2021
Mutational profile of skin lesions in hepatocellular carcinoma patients under tyrosine kinase inhibition: a repercussion of a wide-spectrum activity
Leonardo G da Fonseca, Carla Fuster-Anglada, Cristina Carrera, et al.
Page
of 6